143 related articles for article (PubMed ID: 9004296)
21. 177Lu-EDTMP: a potential therapeutic bone agent.
Ando A; Ando I; Tonami N; Kinuya S; Kazuma K; Kataiwa A; Nakagawa M; Fujita N
Nucl Med Commun; 1998 Jun; 19(6):587-91. PubMed ID: 10234664
[TBL] [Abstract][Full Text] [Related]
22. 16 detector multislice CT versus skeletal scintigraphy in the diagnosis of wrist fractures: value of quantification of 99Tcm-MDP uptake.
Groves AM; Cheow HK; Balan KK; Bearcroft PW; Dixon AK
Br J Radiol; 2005 Sep; 78(933):791-5. PubMed ID: 16110099
[TBL] [Abstract][Full Text] [Related]
23. Soft tissue uptake on 99mTc methylene diphosphonate bone scan imaging: pictorial review.
Kaye J; Hayward M
Australas Radiol; 2002 Mar; 46(1):13-21. PubMed ID: 11966582
[TBL] [Abstract][Full Text] [Related]
24. Effects of acute administration of ethane hydroxydiphosphonate (EHDP) on skeletal scintigraphy with technetium-99m methylene diphosphonic acid (Tc-MDP) in the rat.
Watt I; Hill P
Br J Radiol; 1981 Jul; 54(643):592-6. PubMed ID: 6455174
[TBL] [Abstract][Full Text] [Related]
25. Technetium-99m-methylene diphosphonate--a superior agent for skeletal imaging: comparison with other technetium complexes.
Subramanian G; McAfee JG; Blair RJ; Kallfelz FA; Thomas FD
J Nucl Med; 1975 Aug; 16(8):744-55. PubMed ID: 170385
[TBL] [Abstract][Full Text] [Related]
26. Effects of alternative reconstitution procedures on the labelling efficiency and in vitro stability of 99Tcm-labelled radiopharmaceuticals.
Bogsrud TV; Chen MN; Herold TJ; Mahoney DW; Hung JC
Nucl Med Commun; 1999 Jan; 20(1):61-5. PubMed ID: 9949414
[TBL] [Abstract][Full Text] [Related]
27. A new method for assessing 99Tcm-MDP bone uptake from a bone scan image: quantitative measurement of radioactivity in global skeletal regions of interest.
D'Addabbo A; Rubini G; Mele M; Lauriero F
Nucl Med Commun; 1992 Jan; 13(1):55-60. PubMed ID: 1594171
[TBL] [Abstract][Full Text] [Related]
28. 99Tcm-MDP Imaging of Osteopetrosis: Case Report.
Zheng LC; OuYang XL; Liu GC; Zhang WJ; Zhang XM
Medicine (Baltimore); 2015 Jun; 94(22):e929. PubMed ID: 26039130
[TBL] [Abstract][Full Text] [Related]
29. [Evaluation of 113mIn-DTPMP and 99mTc-MDP for bone scanning].
Yang JS
Zhonghua Fang She Xue Za Zhi; 1984 Feb; 18(1):58-62. PubMed ID: 6236062
[No Abstract] [Full Text] [Related]
30. 99Tcm-p-aminohippuric acid as a new renal agent.
Djokić D; Janković D; Maksin T; Jaksić E; Beatović S; Han R
Nucl Med Commun; 1999 Dec; 20(12):1133-40. PubMed ID: 10664994
[TBL] [Abstract][Full Text] [Related]
31. A report on the incidence of intestinal 99mTc-methylene diphosphonate uptake of bone scans and a review of the literature.
Ergün EL; Kiratli PO; Günay EC; Erbaş B
Nucl Med Commun; 2006 Nov; 27(11):877-85. PubMed ID: 17021428
[TBL] [Abstract][Full Text] [Related]
32. Studies on 177Lu-labeled methylene diphosphonate as potential bone-seeking radiopharmaceutical for bone pain palliation.
Abbasi IA
Nucl Med Biol; 2011 Apr; 38(3):417-25. PubMed ID: 21492790
[TBL] [Abstract][Full Text] [Related]
33. A comparison of bone imaging with Tc-99m DPD and Tc-99m MDP: concise communication.
Buell U; Kleinhans E; Zorn-Bopp E; Reuschel W; Muenzing W; Moser EA; Seiderer M
J Nucl Med; 1982 Mar; 23(3):214-7. PubMed ID: 6460854
[TBL] [Abstract][Full Text] [Related]
34. Comparison of 99Tcm-labelled MDP and DMAD bone scanning agents in patients with advanced breast cancer.
Coleman RE; Meier CA; Rubens RD; Fogelman I
Nucl Med Commun; 1988 Jul; 9(7):481-5. PubMed ID: 3173907
[TBL] [Abstract][Full Text] [Related]
35. The role of 99Tcm-sestamibi scintigraphy in the staging and prediction of the therapeutic response of stage IV neuroblastoma: comparison with 131I-MIBG and 99Tcm-MDP scintigraphy.
Burak Z; Yüksel DA; Cetingül N; Kantar M; Ozkiliç H; Moretti JL
Nucl Med Commun; 1999 Nov; 20(11):991-1000. PubMed ID: 10572908
[TBL] [Abstract][Full Text] [Related]
36. [Magistral preparation of methylene diphosphonate and its clinical evaluation in radionuclide diagnosis of the skeleton].
Lepej J; Marosová A; Altmann P; Reznák I; Podmajerský M
Cesk Farm; 1989 Jul; 38(5):204-9. PubMed ID: 2790989
[TBL] [Abstract][Full Text] [Related]
37. Biokinetics of bone tracers by means of deconvolution analysis--comparison of 99mTc MDP, 99mTc DPD and 99mTc EHDP.
Knop J; Stritzke P; Kröger E; Schneider C; Wasmus G
Nuklearmedizin; 1982 Aug; 21(4):145-9. PubMed ID: 6216459
[TBL] [Abstract][Full Text] [Related]
38. Radioleucoscintigraphy in osteoarthritis. Is there an inflammatory component?
al-Janabi MA; Solanki K; Critchley M; Smith ML; Britton KE; Huskisson EC
Nucl Med Commun; 1992 Oct; 13(10):706-12. PubMed ID: 1491834
[TBL] [Abstract][Full Text] [Related]
39.
Mandiwana V; Kalombo L; Grobler A; Zeevaart JR
Appl Radiat Isot; 2018 Nov; 141():51-56. PubMed ID: 30170270
[TBL] [Abstract][Full Text] [Related]
40. Technetium-99m MDP vs technetium-99m dicarboxypropane diphosphonate. A clinical comparison in various pathologic conditions.
Godart G; Durez M; Bevilacqua M; Abramovici J; Robience Y
Clin Nucl Med; 1986 Feb; 11(2):92-7. PubMed ID: 3769350
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
